M
Moses R. Kamya
Researcher at Makerere University
Publications - 504
Citations - 15407
Moses R. Kamya is an academic researcher from Makerere University. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 60, co-authored 435 publications receiving 12598 citations. Previous affiliations of Moses R. Kamya include Mulago Hospital.
Papers
More filters
Journal ArticleDOI
Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy
Andrew Kambugu,David B. Meya,Joshua Rhein,Meagan O’Brien,Edward N. Janoff,Allan R. Ronald,Allan R. Ronald,Moses R. Kamya,Harriet Mayanja-Kizza,Merle A. Sande,Paul R. Bohjanen,David R. Boulware +11 more
TL;DR: Significant CM-associated mortality persists, despite the administration of amphotericin B and HIV therapy, because of the high mortality rate before receipt of HAART and because of immune reconstitution inflammatory syndrome-related complications after HAART initiation.
Journal ArticleDOI
Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start HIV Therapy in Resource-Limited Settings
David B. Meya,Yukari C. Manabe,Yukari C. Manabe,Barbara Castelnuovo,Bethany Cook,Ali Elbireer,Ali Elbireer,Andrew Kambugu,Andrew Kambugu,Moses R. Kamya,Paul R. Bohjanen,David R. Boulware +11 more
TL;DR: The number needed to test and treat with CRAG screening and fluconazole to prevent 1 CM case is 11.3 (95% CI, 7.9−17.1) at costs of $190 (95%) CI, $132−$287.
Journal ArticleDOI
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities.
Danica Helb,Kevin K. A. Tetteh,Philip L. Felgner,Jeff Skinner,Alan Hubbard,Emmanuel Arinaitwe,Harriet Mayanja-Kizza,Isaac Ssewanyana,Moses R. Kamya,James G. Beeson,Jordan W. Tappero,David L. Smith,Peter D. Crompton,Philip J. Rosenthal,Grant Dorsey,Chris Drakeley,Bryan Greenhouse +16 more
TL;DR: Development of simple ELISA-based assays derived from the successful selection strategy outlined here offers the potential to generate rich epidemiologic surveillance data that will be widely accessible to malaria control programs.
Journal ArticleDOI
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Grant Dorsey,Sarah G. Staedke,Tamara D. Clark,Denise Njama-Meya,Bridget Nzarubara,Catherine Maiteki-Sebuguzi,Christian Dokomajilar,Moses R. Kamya,Philip J. Rosenthal +8 more
TL;DR: A single-blind randomized clinical trial, conducted between November 2004 and June 2006, of treatment for all episodes of uncomplicated malaria in children in an urban community in Kampala, Uganda, was conducted as mentioned in this paper.
Journal ArticleDOI
Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 Genes and Clinical Response to Chloroquine in Kampala, Uganda
TL;DR: In evaluations of known polymorphisms in parasites from patients with uncomplicated malaria in Kampala, Uganda, the presence of 8 pfcrt mutations and 2 pfmdr-1 mutations did not correlate with clinical response to therapy with chloroquine, suggesting that other factors may contribute to clinical outcomes.